This constipation care plan leverages NANDA-I diagnosis and evidence-based guidelines (NICE, ACP, Cochrane) to address causes like inadequate fiber intake, sedentary lifestyles, and medication side effects. Key interventions prioritize osmotic laxatives (first-line per Cochrane), dietary fiber optimization (25–30g/day, ESPEN/AND guidelines), and activity promotion (WHO standards). Metrics like the Bristol Scale, CRAS risk scoring, and PAC-SYM assessments track progress toward SMART goals: improved stool frequency, reduced straining, and sustained bowel regularity. Integrates EHR tools, deprescribing protocols (Beers Criteria), and cultural dietary adaptations for compliance with Joint Commission and CMS standards, adaptable to acute, home, or pediatric care.